Waters Andrew Alliance
AcquiredFounded 2011 · $14.0M raised
- Employees
- 51–200
- Founded
- 2011
- Business Model
- B2B
- Website
- andrewalliance.com
- Total Funding
- $14.0M
- Last Round
- $14.0M Series CJun 2018
- Rounds
- 2
About
Andrew Alliance, operating under Waters Corporation after its acquisition, designs and manufactures the Andrew+ pipetting robot and OneLab cloud-connected lab software for life science laboratories. The company's platform automates complete liquid handling workflows — from serial dilutions to sample preparation — using standard laboratory pipettes and labware, ensuring reproducibility and full audit traceability. Its customers include pharmaceutical, bioprocessing, genomics, and clinical research labs. Andrew Alliance was founded in Geneva in 2011 and acquired by Waters Corporation (NYSE: WAT) to expand its lab automation portfolio.
Summary
Waters Andrew Alliance is a Biotech company, founded in 2011. It has raised $14.0M in total across 2 rounds, most recently a $14.0M Series C round in Jun 2018. Investors include Waters Corporation, Omega Funds and Tecan Group.
Tech & App Stack
1 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2020
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.